Alkermes Inc. plc (ALKS) is a publicly traded Healthcare sector company. As of October 21, 2026, ALKS trades at $44.02 with a market cap of $7.40B and a P/E ratio of 104.67. ALKS moved -1.43% today. Year to date, ALKS is +53.86%; over the trailing twelve months it is +38.25%. Its 52-week range spans $25.17 to $55.67. Analyst consensus is buy with an average price target of $58.77. Rallies surfaces ALKS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ALKS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $44.02 |
| Market Cap | $7.40B |
| P/E Ratio | 104.67 |
| EPS | $0.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.67 |
| 52-Week Low | $25.17 |
| Volume | 1.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.67B |
| Net Income | $66.12M |
| Gross Margin | 84.56% |
14 analysts cover ALKS: 0 strong buy, 10 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $58.77.